Skip to content

Analysis of a Short Assessment of Post Intensive Care Syndrome (PICS)

Analysis of a Short Assessment of Post Intensive Care Syndrome (PICS)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04175236
Enrollment
9
Registered
2019-11-22
Start date
2018-06-19
Completion date
2019-11-04
Last updated
2021-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postintensive Care Syndrome

Brief summary

To present a proposal for a set of outcome measurement instruments (OMIs) of post intensive care syndrome (PICS) in settings of outpatient healthcare service.

Interventions

None listed

Sponsors

Claudia Spies
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged ≥ 18 years, whose intensive care treatment has already been completed * The patients were interviewed in the Klinikum Ernst von Bergmann, Peumologisches Beatmungszentrum, Bad Belzig, as well as in the pain clinic of the Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité - Universitätsmedizin Berlin

Exclusion criteria

Patients with a legal guardian or authorized representative

Design outcomes

Primary

MeasureTime frameDescription
Post Intensive Care Syndrome (PICS)06/2018 - 11/2019The composite outcome measure PICS of the patient is measured according to Needham et al 2012: new impairment or worsening of health after intensive care unit stay and at the same time clinically significant distress in at least one of the following outcome measurement instruments: Patient Health Questionnaires (PHQ-9, PHQ-8, PHQ-4), Generalized Anxiety Disorder Scale-7 (GAD-7), Impact of Event Scale (IES), Impact of Event Scale Revised (IES-R), MiniCog, Animal Naming Test, Trail Making Test (TMT-A, TMT-B), Repeatable Battery for the Assessment of Neuropsychological Satus (RBANS), Timed Up-and-Go (TUG), Handgrip Strength, 2-Minute Walk Test (2-MWT), Short Physical Performance Battery (SPPB).

Secondary

MeasureTime frameDescription
Subjective Health II06/2018 - 11/2019Patients were asked to rate their quality of life, measured by EQ-5D-5L
Subjective Health III06/2018 - 11/2019Patients were asked to rate their quality of life, measured by WHO Disability Assessment Schedule (WHODAS 2.0)
Subjective Health I06/2018 - 11/2019Patients were asked to rate their quality of life, measured by EQ-5D-3L
Cognition06/2018 - 11/2019Cognition is measured by the sum scores of the following outcome measurement instruments: MiniCog, Animal Naming Test, Trail Making Test (TMT-A, TMT-B), Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).
Physical Health06/2018 - 11/2019Physical health is measured by the sum scores of the following outcome measurement instruments: Timed Up-and-Go (TUG), Handgrip Strength, 2-Minute Walk Test (2-MWT), Short Physical Performance Battery (SPPB).
Mental Health06/2018 - 11/2019Mental health of the patient is measured by the sum scores of the following outcome measurement instruments: Patient Health Questionnaire (PHQ-9, PHQ-8, PHQ-4), Generalized Anxiety Disorder Scale-7 (GAD-7), Impact of Event Scale (IES), Impact of Event Scale Revised (IES-R).

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026